Agree GC, PYC is certainly ticking boxes, and I'm starting to...

Agree GC, PYC is certainly ticking boxes, and I'm starting to get excited too. Novel technology, the high probability of success approach, a CEO who knows the science backwards, and can sell the story to boot, I think this PKD angle is far more simple and appealing for many (individuals and larger groups)- plus the target market is, just... wow. And in a broader sense, the biotech sector seems to be coming back to life- at least both my portfolio and watchlist certainly are.

With regard to NEU, I'm just glad I got on this train towards the start of the line ad not at 8 bucks- honestly I just followed hottod's posts right to the dining carriage, read the menu, and loaded up lol. I wouldn't be surprised to see more and more NEU names appear over here, there's already TripAces, good1234, TB, fyfee, and I'm sure a few others who probably read but don't post. We also have te benefit of some seriously skilled and hard-working research gurus (hottod and Medicine Man to name a couple of obvious ones).

Seriously exciting times!

GLA.